Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008)
- PMID: 18410188
- DOI: 10.1037/0735-7044.122.2.483
Social behavior phenotypes in fragile X syndrome, autism, and the Fmr1 knockout mouse: theoretical comment on McNaughton et al. (2008)
Abstract
Comments on the article by C. H. McNaughton et al.. Individuals with fragile X syndrome (FXS) show varying degrees of social behavior disturbances, from social anxiety to autism. This variability of social behavior phenotypes in FXS is likely to be due to interactions of Fmr1 with other gene variants and environmental factors during brain development, although very little is known about the specific genetic and neural mechanisms involved. The Fmr1 knockout mouse is an important experimental resource for elucidating the neural mechanisms of social anxiety, social reward, and social cognition. However, studies of social behavior phenotypes in the Fmr1 knockout mouse are still in early stages. McNaughton et al provide important new information on these phenotypes in the Fmr1 knockout mouse through their use of novel, detailed behavioral analysis to identify signs of increased social anxiety and social cognition deficits. Their significant refinements in measurement of social behavior phenotypes will help to advance future efforts to elucidate the genetic and neural mechanisms underlying social behavior disturbances in FXS and autism.
Comment on
-
Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.Behav Neurosci. 2008 Apr;122(2):293-300. doi: 10.1037/0735-7044.122.2.293. Behav Neurosci. 2008. PMID: 18410169
Similar articles
-
Altered anxiety-related and social behaviors in the Fmr1 knockout mouse model of fragile X syndrome.Genes Brain Behav. 2005 Oct;4(7):420-30. doi: 10.1111/j.1601-183X.2005.00123.x. Genes Brain Behav. 2005. PMID: 16176388
-
Evidence for social anxiety and impaired social cognition in a mouse model of fragile X syndrome.Behav Neurosci. 2008 Apr;122(2):293-300. doi: 10.1037/0735-7044.122.2.293. Behav Neurosci. 2008. PMID: 18410169
-
Altered expression of Autism-associated genes in the brain of Fragile X mouse model.Biochem Biophys Res Commun. 2009 Feb 20;379(4):920-3. doi: 10.1016/j.bbrc.2008.12.172. Epub 2009 Jan 10. Biochem Biophys Res Commun. 2009. PMID: 19138667
-
The behavioral phenotype of FMR1 mutations.Am J Med Genet C Semin Med Genet. 2010 Nov 15;154C(4):469-76. doi: 10.1002/ajmg.c.30277. Am J Med Genet C Semin Med Genet. 2010. PMID: 20981777 Review.
-
Advances in behavioral genetics: mouse models of autism.Mol Psychiatry. 2008 Jan;13(1):4-26. doi: 10.1038/sj.mp.4002082. Epub 2007 Sep 11. Mol Psychiatry. 2008. PMID: 17848915 Review.
Cited by
-
Therapeutic strategies in fragile X syndrome: dysregulated mGluR signaling and beyond.Neuropsychopharmacology. 2012 Jan;37(1):178-95. doi: 10.1038/npp.2011.137. Epub 2011 Jul 27. Neuropsychopharmacology. 2012. PMID: 21796106 Free PMC article. Review.
-
Altered nocifensive behavior in animal models of autism spectrum disorder: The role of the nicotinic cholinergic system.Neuropharmacology. 2016 Dec;111:323-334. doi: 10.1016/j.neuropharm.2016.09.013. Epub 2016 Sep 13. Neuropharmacology. 2016. PMID: 27638450 Free PMC article.
-
Anhedonia and Hyperhedonia in Autism and Related Neurodevelopmental Disorders.Curr Top Behav Neurosci. 2022;58:237-254. doi: 10.1007/7854_2022_312. Curr Top Behav Neurosci. 2022. PMID: 35397066
-
The autism diagnosis in translation: shared affect in children and mouse models of ASD.Autism Res. 2011 Oct;4(5):317-35. doi: 10.1002/aur.216. Epub 2011 Aug 31. Autism Res. 2011. PMID: 21882361 Free PMC article. Review.
-
Systematic review of pharmacological treatments in fragile X syndrome.BMC Neurol. 2009 Oct 13;9:53. doi: 10.1186/1471-2377-9-53. BMC Neurol. 2009. PMID: 19822023 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical